Xybion

Xybion was founded in 1977 by Dr. Paul Frost to support pharmaceutical companies in managing Preclinical R&D and drug safety testing for FDA submissions. (1) In 2008, Xybion was acquired by The Banerjee Group, led by Dr. Pradip K. Banerjee, who continued to invest in the companys core products, such as Pristima, while also developing new products and markets. As technology advanced, Xybion remained at the forefront of innovative technology solutions, by developing a cloud-based digital acceleration platform to support global, national, and regional clients across regulated industries. Today, Xybion® is a global, cloud based end-to-end Industry software solutions and technology driven services company dedicated to helping corporations solve business problems and accelerate the pace of innovation. Xybion helps companies in highly regulated environments: Transform into a digital workplace to become more efficient and reduce costs Improve regulatory adherence and be compliance-ready, always Accelerate the pace of innovation Since 1977, Xybion has helped companies become more efficient, reduce operational costs and manage compliance, regulatory adherence, quality, and risk through innovative solutions and patent-pending algorithms. Xybions expansive industry expertise enabled development of unified cloud based software systems across research and development, preclinical to launch phase, labs, drug discovery, EHSQ, LIMS, employer COVID-19 tracking, and clinical trial risk management with a focus on automating resource intensive tasks and mitigating quality and compliance risk areas within highly regulated industries across multiple sites, locations, work areas, and functions through the utilization of its proprietary digital acceleration platform that enables regulatory compliance and remote administration.